Peter O'Dwyer

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Genentech
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BMS
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GSK
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Five Prime
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    FortySeven
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Syndax
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BBI
    Date added:
    09/20/2023
    Date updated:
    09/20/2023

Pages

Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes